NBIX 最新季度财报
公布日期7/30/2026
实际每股收益(美元)1.43
实际营收(美元)959.00M
本页面提供详细的 Neurocrine Biosciences Inc 财报数据,包括最新财报、下一次财报发布日期、历史数据及 Neurocrine Biosciences Inc 财报电话会相关新闻。
| 发布日期 | 报告期末 | 每股收益/预测值 | 营收/预测值 | 每股收益超预期幅度 % | 营收超预期幅度 % |
|---|---|---|---|---|---|
| 7/30/2026 | 06/2026 | 1.43/1.34 | 959.00M/885.80M | 6.51% | 8.26% |
| 5/5/2026 | 03/2026 | 1.97/1.17 | 814.50M/772.58M | 67.68% | 5.43% |
| 2/11/2026 | 12/2025 | 1.54/1.88 | 805.50M/791.96M | -18.40% | 1.71% |
| 10/28/2025 | 09/2025 | 2.11/1.59 | 794.90M/746.52M | 32.89% | 6.48% |
| 7/30/2025 | 06/2025 | 1.09/0.97 | 687.50M/652.61M | 11.80% | 5.35% |
| 5/5/2025 | 03/2025 | 0.08/0.55 | 572.60M/562.17M | -85.47% | 1.86% |
| 2/6/2025 | 12/2024 | 1.03/1.56 | 627.70M/628.99M | -33.80% | -0.20% |
| 10/30/2024 | 09/2024 | 1.28/1.47 | 622.10M/600.63M | -12.72% | 3.57% |